Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/american-public-health-association/age-specific-seroprevalence-of-hiv-hepatitis-b-virus-and-hepatitis-c-ACOi0tWnrO
References (15)
-
Klaus Stark, Ulrich Bienzle, Richard Vonk, I. Guggenmoos-Holzmann (1997)
History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.International journal of epidemiology, 26 6
-
A. Neaigus, S. Friedman, B. Jose, M. Goldstein, R. Curtis, G. Ildefonso, D. Jarlais (1996)
High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors.Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 11 5
-
Orin Levine, Orin Levine, David Vlahov, Jane Koehler, S. Cohn, A. Spronk, K. Nelson (1995)
Seroepidemiology of hepatitis B virus in a population of injecting drug users. Association with drug injection patterns.American journal of epidemiology, 142 3
-
D. Prevots, D. Allen, J. Lehman, T. Green, L. Petersen, M. Gwinn (1996)
Trends in human immunodeficiency virus seroprevalence among injection drug users entering drug treatment centers, United States, 1988-1993.American journal of epidemiology, 143 7
-
Deets Hb, F. Mesquita, E. Massad, R. Bueno, Lopes Gt, Ruiz Ma, M. Burattini (1996)
HIV and infections of similar transmission patterns in a drug injectors community of Santos, Brazil.Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 12 1
-
W. Loxley, M. Phillips, S. Carruthers, J. Bevan (1997)
The Australian Study of HIV and Injecting Drug Use. Part I: prevalence for HIV, hepatitis B and hepatitis C among injecting drug users in four Australian cities.Drug and alcohol review, 16 3
-
(1989)
Ga: Centers for Disease Control and Preven tion Inter pretation and use of the Western blot assay for serodi agnosis of human immunodeficiency virus type 1 in fections -
O. Levine, D. Vlahov, R. Brookmeyer, S. Cohn, K. Nelson (1996)
Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users.The Journal of infectious diseases, 173 3
-
J. Zeldis, Sunita Jain, Ken Kuramoto, Cheryl Richards, K. Sazama, Steven Samuels, P. Holland, N. Flynn (1992)
Seroepidemiology of viral infections among intravenous drug users in northern California.The Western journal of medicine, 156 1
-
R. Garfein, D. Vlahov, N. Galai, M. Doherty, K. Nelson (1996)
Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.American journal of public health, 86 5
-
N. Crofts, L. Nigro, Kimberley Oman, E. Stevenson, John Sherman (1997)
Methadone maintenance and hepatitis C virus infection among injecting drug users.Addiction, 92 8
-
(2000)
HCV, HBV and HIV infections among young, street recruited injection drug users (IDUs): the Collaborative Injection Drug Users Study (CIDUS II) -
(2002)
American Journal of Public Health Murrill et al. | Peer Reviewed | Research and Practice | -
(2000)
Hep atitis B vaccination program for injecting drug users— Pierce County -
W. Wiebel, A. Jimenez, W. Johnson, L. Ouellet, B. Jovanovic, T. Lampinen, James Murray, Mary O'Brien (1996)
Risk behavior and HIV seroincidence among out-of-treatment injection drug users: a four-year prospective study.Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 12 3
- Publisher
- American Public Health Association
- Copyright
- Copyright © 2002 by the American Public Health Association
- ISSN
- 0090-0036
- eISSN
- 1541-0048
- DOI
- 10.2105/AJPH.92.3.385
- Publisher site
- See Article on Publisher Site
Abstract
Objectives. This study measured age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus (HCV) infection among injection drug users (IDUs) admitted to drug treatment programs in 6 US cities. Methods. Remnant sera collected from persons entering treatment with a history of illicit drug injection were tested for antibodies to HIV, hepatitis C (anti-HCV), and hepatitis B core antigen (anti-HBc). Results. Prevalence of anti-HBc and anti-HCV increased with age and reached 80% to 100% among older IDUs in all 6 cities. Although overall age-specific HIV prevalence was lower than anti-HCV or anti-HBc, this prevalence was greater in the Northeast than in the Midwest and West. Conclusions. The need continues for effective primary prevention programs among IDUs specifically targeting young persons who have recently started to inject drugs. (Am J Public Health. 2002;92:385–387)
Journal
American Journal of Public Health – American Public Health Association
Published: Mar 1, 2002